News
Better screening needed for sickle cell and thalassaemia
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7256.260/b (Published 29 July 2000) Cite this as: BMJ 2000;321:260
- Jenny Blythe
- BMJ
Universal antenatal screening for sickle cell disease and thalassaemia may be cost effective in some areas of the United Kingdom, says a report from the Wessex Institute for Health Research and Development.
Universal antenatal and neonatal screening was previously recommended in areas in which 15% …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.